Revance Therapeutics Inc (RVNC)
3.08
+0.01
(+0.33%)
USD |
NASDAQ |
Dec 24, 16:00
Revance Therapeutics Gross Profit (Annual): 159.68M for Dec. 31, 2023
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Recursion Pharmaceuticals Inc | 1.289M |
| Regeneron Pharmaceuticals Inc | 11.30B |
| Ligand Pharmaceuticals Inc | 120.80M |
| MEI Pharma Inc | -- |
| Cellectar Biosciences Inc | -- |